Home
Conditions
Small-cell Lung Cancer

Clinical trial condition

Small-cell Lung Cancer

Explore clinical trials studying Small-cell Lung Cancer. Study availability and eligibility vary by location and protocol.

75 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Small-cell Lung Cancer trial results

Enrolling by Invitation

Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

NCT06816966

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Fujian Medical University Union Hospital, Fuzhou, Fujian, China

View Trial Details

Not Yet Recruiting

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

NCT07625644

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

NCT07545954

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not Yet Recruiting

A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors

NCT07623369

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +69 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

SCLC Tarlatamab Blood Collection

NCT07468656

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.

NCT06789796

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic

NCT06497543

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Yongchang Zhang Changsha, Hunan, China

View Trial Details

Completed

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

NCT04010357

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extrapulmonary Small Cell Carcinoma, +10 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

NCT07050472

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Peking University Cancer Hospital and Institute Beijing, Beijing Municipality, China

View Trial Details

Completed

Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors

NCT04640480

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +45 more
Locations: CHA Medical Center Seongnam-si, Gyeonggi-do, South Korea

The Severance Hospital of the Yonsei University Seoul, South Korea

The Catholic University of Korea Seoul ST. Mary's Hospital Seoul, South Korea

View Trial Details

Small-cell Lung Cancer

Small-cell Lung Cancer trial results

Related conditions